{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:56:41Z","timestamp":1790290601499,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T00:00:00Z","timestamp":1624320000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Project of Heilongjiang province higher education teaching reform","award":["SJGY20190705"],"award-info":[{"award-number":["SJGY20190705"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Head Face Med"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Oral cavity cancer ranks the sixth most common malignancy worldwide, of which oral squamous cell carcinoma is the predominant type. This study aimed to investigate the function and the underlying mechanism of resistin like beta (RETNLB) in oral squamous cell carcinoma.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The data of oral squamous cell carcinoma samples from The Cancer Genome Atlas database was used to examine RETNLB expression and assess its correlation with the clinical outcomes. Biological functions of RETNLB on the growth, invasion and migration of cells were determined by cell counting kit 8, clonogenic growth, and Transwell assays. Gene set enrichment analysis was utilized to identify the important gene sets associated with RETNLB expression, which was further confirmed by western blot.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>We found that RETNLB was upregulated in oral squamous cell carcinoma tissues and cells. High expression of RETNLB was closely linked to age and pathological tumor, and significantly related to poor survival of oral squamous cell carcinoma patients. Further functional experiments showed that knockdown of RETNLB significantly reduced the viability, mobility and invasiveness of cells. Moreover, gene set enrichment analysis suggested that Toll-like receptor signaling pathway was significantly correlated with high RETNLB expression. Further western blot analysis verified that silencing RETNLB could notably suppress the protein levels of Toll-like receptor 2, Toll-like receptor 4 and phosphor- extracellular signal-regulated kinase.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>These results suggested that downregulation of RETNLB may restrain the progression of oral squamous cell carcinoma by inactivating TLR\/2\/4\/ERK pathway.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13005-021-00272-4","type":"journal-article","created":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T06:08:38Z","timestamp":1624342118000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Investigating resistin like beta (RETNLB) as a tumor promoter for oral squamous cell carcinoma"],"prefix":"10.1186","volume":"17","author":[{"given":"Hong","family":"Jin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Wen","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang-Yang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,6,22]]},"reference":[{"issue":"3","key":"272_CR1","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1016\/j.oraloncology.2013.12.008","volume":"50","author":"H Polanska","year":"2014","unstructured":"Polanska H, Raudenska M, Gumulec J, Sztalmachova M, Adam V, Kizek R, et al. Clinical significance of head and neck squamous cell cancer biomarkers. Oral Oncol. 2014;50(3):168\u201377. https:\/\/doi.org\/10.1016\/j.oraloncology.2013.12.008.","journal-title":"Oral Oncol"},{"issue":"1","key":"272_CR2","doi-asserted-by":"publisher","first-page":"6","DOI":"10.5681\/joddd.2014.002","volume":"8","author":"H Mortazavi","year":"2014","unstructured":"Mortazavi H, Baharvand M, Mehdipour M. Oral potentially malignant disorders: an overview of more than 20 entities. J Dent Res Dent Clin Dent Prospects. 2014;8(1):6\u201314. https:\/\/doi.org\/10.5681\/joddd.2014.002.","journal-title":"J Dent Res Dent Clin Dent Prospects"},{"issue":"1","key":"272_CR3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.oraloncology.2007.06.011","volume":"44","author":"MW Lingen","year":"2008","unstructured":"Lingen MW, Kalmar JR, Karrison T, Speight PM. Critical evaluation of diagnostic aids for the detection of oral cancer. Oral Oncol. 2008;44(1):10\u201322. https:\/\/doi.org\/10.1016\/j.oraloncology.2007.06.011.","journal-title":"Oral Oncol"},{"issue":"1","key":"272_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.cden.2017.09.001","volume":"62","author":"JA Valdez","year":"2018","unstructured":"Valdez JA, Brennan MT. Impact of Oral Cancer on quality of life. Dent Clin N Am. 2018;62(1):143\u201354. https:\/\/doi.org\/10.1016\/j.cden.2017.09.001.","journal-title":"Dent Clin N Am"},{"issue":"1","key":"272_CR5","doi-asserted-by":"publisher","first-page":"38834","DOI":"10.1038\/srep38834","volume":"6","author":"S Liu","year":"2016","unstructured":"Liu S, Liu L, Ye W, Ye D, Wang T, Guo W, et al. High vimentin expression associated with lymph node metastasis and predicated a poor prognosis in Oral squamous cell carcinoma. Sci Rep. 2016;6(1):38834. https:\/\/doi.org\/10.1038\/srep38834.","journal-title":"Sci Rep"},{"issue":"10","key":"272_CR6","first-page":"1427","volume":"27","author":"T Shibahara","year":"2017","unstructured":"Shibahara T. Oral cancer -diagnosis and therapy. Clin Calcium. 2017;27(10):1427\u201333 DOI: CliCa171014271433.","journal-title":"Clin Calcium"},{"key":"272_CR7","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/j.cyto.2018.05.014","volume":"110","author":"GM Pine","year":"2018","unstructured":"Pine GM, Batugedara HM, Nair MG. Here, there and everywhere: Resistin-like molecules in infection, inflammation, and metabolic disorders. Cytokine. 2018;110:442\u201351. https:\/\/doi.org\/10.1016\/j.cyto.2018.05.014.","journal-title":"Cytokine."},{"issue":"7","key":"272_CR8","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1016\/j.pt.2016.04.011","volume":"32","author":"WGC Horsnell","year":"2016","unstructured":"Horsnell WGC, Dewals BG. RELMs in the realm of helminths. Trends Parasitol. 2016;32(7):512\u20134. https:\/\/doi.org\/10.1016\/j.pt.2016.04.011.","journal-title":"Trends Parasitol"},{"issue":"2","key":"272_CR9","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1073\/pnas.98.2.502","volume":"98","author":"CM Steppan","year":"2001","unstructured":"Steppan CM, Brown EJ, Wright CM, Bhat S, Banerjee RR, Dai CY, et al. A family of tissue-specific resistin-like molecules. Proc Natl Acad Sci U S A. 2001;98(2):502\u20136. https:\/\/doi.org\/10.1073\/pnas.98.2.502.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"7","key":"272_CR10","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1016\/j.tem.2011.03.005","volume":"22","author":"DR Schwartz","year":"2011","unstructured":"Schwartz DR, Lazar MA. Human resistin: found in translation from mouse to man. Trends Endocrinol Metab. 2011;22(7):259\u201365. https:\/\/doi.org\/10.1016\/j.tem.2011.03.005.","journal-title":"Trends Endocrinol Metab"},{"issue":"6","key":"272_CR11","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/diabetes.51.6.1737","volume":"51","author":"N Shojima","year":"2002","unstructured":"Shojima N, Sakoda H, Ogihara T, Fujishiro M, Katagiri H, Anai M, et al. Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells. Diabetes. 2002;51(6):1737\u201344. https:\/\/doi.org\/10.2337\/diabetes.51.6.1737.","journal-title":"Diabetes."},{"key":"272_CR12","doi-asserted-by":"publisher","first-page":"e9485","DOI":"10.1097\/MD.0000000000009485","volume":"96","author":"WW Hu","year":"2017","unstructured":"Hu WW, Tang CH, Sun Y, et al. Correlation between resistin gene polymorphism and clinical aspects of lung cancer. Medicine (Baltimore). 2017;96:e9485.","journal-title":"Medicine (Baltimore)"},{"issue":"10","key":"272_CR13","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1002\/1873-3468.12655","volume":"591","author":"S Singh","year":"2017","unstructured":"Singh S, Chouhan S, Mohammad N, Bhat MK. Resistin causes G1 arrest in colon cancer cells through upregulation of SOCS3. FEBS Lett. 2017;591(10):1371\u201382. https:\/\/doi.org\/10.1002\/1873-3468.12655.","journal-title":"FEBS Lett"},{"issue":"2","key":"272_CR14","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s10620-008-0355-2","volume":"54","author":"LD Zheng","year":"2009","unstructured":"Zheng LD, Tong QS, Weng MX, He J, Lv Q, Pu JR, et al. Enhanced expression of resistin-like molecule beta in human colon cancer and its clinical significance. Dig Dis Sci. 2009;54(2):274\u201381. https:\/\/doi.org\/10.1007\/s10620-008-0355-2.","journal-title":"Dig Dis Sci"},{"issue":"1","key":"272_CR15","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1007\/s00428-009-0861-4","volume":"456","author":"L Zheng","year":"2010","unstructured":"Zheng L, Weng M, He J, Yang X, Jiang G, Tong Q. Expression of resistin-like molecule beta in gastric cancer: its relationship with clinicopathological parameters and prognosis. Virchows Arch. 2010;456(1):53\u201363. https:\/\/doi.org\/10.1007\/s00428-009-0861-4.","journal-title":"Virchows Arch"},{"key":"272_CR16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.12659\/MSM.895598","volume":"22","author":"R Jiang","year":"2016","unstructured":"Jiang R, Zhao C, Wang X, Wang S, Sun X, Tian Y, et al. Resistin-like molecule-beta promotes invasion and migration of gastric carcinoma cells. Med Sci Monit. 2016;22:937\u201342. https:\/\/doi.org\/10.12659\/MSM.895598.","journal-title":"Med Sci Monit"},{"issue":"5","key":"272_CR17","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1038\/ni.1863","volume":"11","author":"T Kawai","year":"2010","unstructured":"Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity: update on toll-like receptors. Nat Immunol. 2010;11(5):373\u201384. https:\/\/doi.org\/10.1038\/ni.1863.","journal-title":"Nat Immunol"},{"issue":"6","key":"272_CR18","doi-asserted-by":"publisher","first-page":"6814","DOI":"10.18632\/oncotarget.23784","volume":"9","author":"CD Palani","year":"2018","unstructured":"Palani CD, Ramanathapuram L, Lam-Ubol A, Kurago ZB. Toll-like receptor 2 induces adenosine receptor A2a and promotes human squamous carcinoma cell growth via extracellular signal regulated kinases (1\/2). Oncotarget. 2018;9(6):6814\u201329. https:\/\/doi.org\/10.18632\/oncotarget.23784.","journal-title":"Oncotarget."},{"issue":"37","key":"272_CR19","doi-asserted-by":"publisher","first-page":"13596","DOI":"10.1073\/pnas.0404034101","volume":"101","author":"D Artis","year":"2004","unstructured":"Artis D, Wang ML, Keilbaugh SA, He W, Brenes M, Swain GP, et al. RELMbeta\/FIZZ2 is a goblet cell-specific immune-effector molecule in the gastrointestinal tract. Proc Natl Acad Sci U S A. 2004;101(37):13596\u2013600. https:\/\/doi.org\/10.1073\/pnas.0404034101.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"272_CR20","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1172\/JCI16521","volume":"111","author":"MW Rajala","year":"2003","unstructured":"Rajala MW, Obici S, Scherer PE, Rossetti L. Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production. J Clin Invest. 2003;111(2):225\u201330. https:\/\/doi.org\/10.1172\/JCI16521.","journal-title":"J Clin Invest"},{"key":"272_CR21","doi-asserted-by":"publisher","first-page":"1716","DOI":"10.1053\/j.gastro.2009.08.042","volume":"137","author":"MA Hildebrandt","year":"2009","unstructured":"Hildebrandt MA, Hoffmann C, Sherrill-Mix SA, et al. High-fat diet determines the composition of the murine gut microbiome independently of obesity. Gastroenterology. 2009;137:1716\u201324.e1\u20132.","journal-title":"Gastroenterology"},{"issue":"36","key":"272_CR22","doi-asserted-by":"publisher","first-page":"31679","DOI":"10.1074\/jbc.M504008200","volume":"280","author":"C Graveleau","year":"2005","unstructured":"Graveleau C, Zaha VG, Mohajer A, Banerjee RR, Dudley-Rucker N, Steppan CM, et al. Mouse and human resistins impair glucose transport in primary mouse cardiomyocytes, and oligomerization is required for this biological action. J Biol Chem. 2005;280(36):31679\u201385. https:\/\/doi.org\/10.1074\/jbc.M504008200.","journal-title":"J Biol Chem"},{"key":"272_CR23","doi-asserted-by":"publisher","first-page":"5832","DOI":"10.18632\/aging.102979","volume":"12","author":"K Lin","year":"2020","unstructured":"Lin K, Huang J, Luo H, et al. Development of a prognostic index and screening of potential biomarkers based on immunogenomic landscape analysis of colorectal cancer. Aging (Albany NY). 2020;12:5832\u201357.","journal-title":"Aging (Albany NY)"},{"issue":"8","key":"272_CR24","doi-asserted-by":"publisher","first-page":"754","DOI":"10.3748\/wjg.v18.i8.754","volume":"18","author":"LD Zheng","year":"2012","unstructured":"Zheng LD, Yang CL, Qi T, Qi M, Tong L, Tong QS. Effects of resistin-like molecule beta over-expression on gastric cancer cells in vitro. World J Gastroenterol. 2012;18(8):754\u201366. https:\/\/doi.org\/10.3748\/wjg.v18.i8.754.","journal-title":"World J Gastroenterol"},{"issue":"61","key":"272_CR25","doi-asserted-by":"publisher","first-page":"104171","DOI":"10.18632\/oncotarget.22042","volume":"8","author":"X Meng","year":"2017","unstructured":"Meng X, Zhang K, Kong J, Xu L, An G, Qin W, et al. Deletion of resistin-like molecule-beta attenuates angiotensin II-induced abdominal aortic aneurysm. Oncotarget. 2017;8(61):104171\u201381. https:\/\/doi.org\/10.18632\/oncotarget.22042.","journal-title":"Oncotarget."},{"key":"272_CR26","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1097\/01268031-200941001-00146","volume":"41","author":"LK Ng","year":"2009","unstructured":"Ng LK, Hussaini HM, Rich AM, Seymour GJ. TLR2 expression in oral cancer, dysplastic and hyperplastic lesions. Pathology. 2009;41:64\u20135. https:\/\/doi.org\/10.1097\/01268031-200941001-00146.","journal-title":"Pathology."},{"issue":"8","key":"272_CR27","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1007\/s12032-014-0120-7","volume":"31","author":"WH Ren","year":"2014","unstructured":"Ren WH, Zhang LM, Liu HQ, Gao L, Chen C, Qiang C, et al. Protein overexpression of CIRP and TLR4 in oral squamous cell carcinoma: an immunohistochemical and clinical correlation analysis. Med Oncol. 2014;31(8):120. https:\/\/doi.org\/10.1007\/s12032-014-0120-7.","journal-title":"Med Oncol"},{"issue":"1","key":"272_CR28","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-4598-11-33","volume":"11","author":"Z Sun","year":"2012","unstructured":"Sun Z, Luo Q, Ye D, Chen W, Chen F. Role of toll-like receptor 4 on the immune escape of human oral squamous cell carcinoma and resistance of cisplatin-induced apoptosis. Mol Cancer. 2012;11(1):33. https:\/\/doi.org\/10.1186\/1476-4598-11-33.","journal-title":"Mol Cancer"},{"issue":"2","key":"272_CR29","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1183\/09031936.00107811","volume":"39","author":"C Fang","year":"2012","unstructured":"Fang C, Meng Q, Wu H, Eid G, Zhang G, Zhang X, et al. Resistin-like molecule-beta is a human airway remodelling mediator. Eur Respir J. 2012;39(2):458\u201366. https:\/\/doi.org\/10.1183\/09031936.00107811.","journal-title":"Eur Respir J"}],"container-title":["Head &amp; Face Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-021-00272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13005-021-00272-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13005-021-00272-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,22]],"date-time":"2021-06-22T06:08:42Z","timestamp":1624342122000},"score":1,"resource":{"primary":{"URL":"https:\/\/head-face-med.biomedcentral.com\/articles\/10.1186\/s13005-021-00272-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6,22]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["272"],"URL":"https:\/\/doi.org\/10.1186\/s13005-021-00272-4","relation":{},"ISSN":["1746-160X"],"issn-type":[{"value":"1746-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,6,22]]},"assertion":[{"value":"27 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 June 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"20"}}